Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C-Infected Males (MK-8325-002) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, pharmacokinetics and pharmacodynamics of MK-8325 in men with chronic hepatitis C; the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• MK-8325

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 1 | Status: TERMINATED